Compare CABA & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABA | NVEC |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.6M | 335.8M |
| IPO Year | 2019 | 1995 |
| Metric | CABA | NVEC |
|---|---|---|
| Price | $3.39 | $78.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 34.4K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 5.22% |
| EPS Growth | ★ 10.26 | N/A |
| EPS | N/A | ★ 2.12 |
| Revenue | N/A | ★ $25,874,694.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.06 | $55.48 |
| 52 Week High | $3.78 | $82.30 |
| Indicator | CABA | NVEC |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 75.68 |
| Support Level | $2.32 | $64.17 |
| Resistance Level | $3.73 | $82.09 |
| Average True Range (ATR) | 0.20 | 2.13 |
| MACD | 0.06 | 1.11 |
| Stochastic Oscillator | 99.48 | 99.90 |
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.